FDA's elevated meeting status signals transition from biomarker data discussions to Accelerated Approval discussions OS ...

Discover why biomarkers are critical in modern drug discovery and clinical trials, enabling better target validation.

The Global Cardiac Biomarkers Market is driven by the rising prevalence of cardiovascular diseases, demanding rapid, accurate diagnostics. Opportunities lie in technological advancements in biomarker ...

Explore how proteomics in biomarker discovery accelerates diagnostic assay development and improves clinical validation.

The Global Renal Biomarkers Market is driven by increasing chronic kidney disease cases and aging populations, necessitating improved diagnostic tools. Key opportunities include rising demand for ...

Investors are scrutinizing the prospects for some drugs in the pipeline following a string of recent rejections from the U.S.

This article explores multiplexing applications in biopharma and highlights key assay development factors to consider.

MIRAMAR, Fla., March 11, 2026 /PRNewswire/ -- DifGen Pharmaceuticals LLC, a U.S.-based specialty generic pharmaceutical company today announced that the U.S. Food and Drug Administration (FDA) has ...

Interim observations from the Phase 2 TRAILHEAD study show continued improvement in handgrip strength, overall stability of elbow and shoulder strength in new dynamometry measurements Greater ...

The metabolism–cancer axis is currently at a critical inflection point. A landmark August 2025 JAMA Oncology study reported a 17% reduction in overall ...

Many people know that finding cancer early, before it spreads, may help increase the chances of treating and surviving cancer.1 But navigating risk factors and getting ahead can ...

New analysis of Gazyva® shows the drug significantly reduces disease activity in adults with systemic lupus erythematosus.